期刊文献+

联合检测高尔基体糖蛋白-73与甲胎蛋白在原发性肝癌中的诊断意义 被引量:2

Significance of golgi protein 73 and alpha-fetoprotein expression in diagnosis of primary hepatic cancer
下载PDF
导出
摘要 目的评价联合检测高尔基体糖蛋白-73(GP73)与甲胎蛋白(AFP)对原发性肝癌的诊断意义。方法采用酶联免疫吸附试验(ELISA)定量检测50例原发性肝癌和50例健康对照者血清GP73与AFP的表达,分别分析比较不同临床病理指标及其联合检测的意义。结果原发性肝癌组中GP73与AFP均明显高于对照组[GP73:309.56±192.33)ng/ml﹠(22.11±8.52)ng/ml;AFP:(400.31±214.49)μg/L﹠(4.55±6.87)μg/L],差异均有统计学意义(t分别=10.58、13.04,P<0.05)。GP73与AFP的联合检测敏感度最高达到85.20%,其特异性、阳性预测值和阴性预测值分别为92.30%、91.70%、86.20%。原发性肝癌患者中GP73表达与血清AFP水平、肿瘤直径、TNM分期无关(t分别=0.25、0.25、0.22,P均>0.05),与肝硬化相关(t=1.72,P<0.05)。结论 GP73高表达于PHC,可成为PHC较好的诊断标志物。联合AFP检测有助于PHC的诊断。 Objective To investigate the expression of golgi protein 73(GP73) and alpha-fetoprotein(AFP) in primary hepatic cancer(PHC) and analyze their clinical significance.Methods Fifty PHC and Fifty normal liver specimens were included in the study.The expression of GP73,and AFP in these specimens were detected by Enzyme-linked immunosorbent assay.The correlation of the expression of these proteins with clinical pathology parameters in PHC was analyzed.Results The expression levels of GP73 and AFP were significantly higher in PHC(GP73:309.56±192.33 vs.22.11±8.52;AFP:400.31±214.49 vs.4.55±6.87;t =10.58,13.04,P0.05).The sensitivity of combined detection including GP73 and AFP for PHC was up to 85.20%,and its specificity,positive predictive value and negative predictive values were 92.30%,91.70%,86.20%.The expression of GP73 in the patients with primary hepatocellular carcinoma was not associated with serum level of AFP,TNM stage,and tumor diameter(t=0.25,0.25,0.22,P0.05);was associated with liver cirrhosis(t=1.72,P0.05).Conclusions GP73 is highly expressed in PHC and can be used as a diagnostic marker for PHC.Combined detection of GP73 and AFP is helpful for diagnosis of PHC.
作者 汪竹峰
出处 《全科医学临床与教育》 2011年第6期616-618,共3页 Clinical Education of General Practice
关键词 高尔基体糖蛋白-73 甲胎蛋白 原发性肝癌 golgi protein 73 alpha-fetoprotein primary hepatic cancer
  • 相关文献

参考文献5

  • 1高松,崔书中,巴明臣.GP73在肝癌诊断中的研究现状及前景[J].中华肝胆外科杂志,2010,16(12):961-963. 被引量:7
  • 2Marrero JA,Romano PR,Nikulaeva O,et a1.GP73.a resident Golgi glycoprotein,is a novel serum marker for hepatocellular carcinoma[J].J Hepatl,2005,43(6):1007-1012.
  • 3洪法水,王雪峰,刘超,苏国兴,宋卫平,吴康,陶冶,赵贵文.Ce^(3+)对菠菜D1/D2/Cytb559复合物影响的光谱学研究[J].中国科学(B辑),2002,32(6):519-526. 被引量:2
  • 4Hong F S, Wang L, Meng X X, et al. The effect of cerium (Ⅲ) on the chlorophyll formation in spinach. Biological Trace Element Research, 2002, 89:263-275
  • 5Hu JS,Wu DW,Ling S,et al.GP73 a resident Golgi glycoprotein is sensibility and specificity for hepatocellular carcinoma of diagnosis in a hepatitis B endemic Asia population[J].Med Oncol,2010,27(2):339-345.

二级参考文献34

  • 1杜林方,梁厚果.牛皮菜叶中三种不同光化学活性的PS Ⅱ反应中心复合物的纯化和特性[J].植物生理学报(0257-4829),1993,19(1):9-16. 被引量:2
  • 2沈博礼,戴新宾.稀土对小麦叶绿体光化学反应的效应[J].稀土,1994,15(2):71-72. 被引量:34
  • 3吴孟超.肝癌外科综合治疗的现状和前景[J].中华肝胆外科杂志,2006,12(1):1-4. 被引量:58
  • 4Maitra A,Thuluvath PJ.GP73 and liver disease:a(Golgi)complex enigma.Am J Gastroenterol,2004,99:1096-1098.
  • 5Kladney RD,Bulla GA,Guo L,et al.GP73,a novel Golgilocalized protein upregulated by viral infection.Gene,2000,249:53-65.
  • 6Kladney RD,Cui X,Bulla GA,et al.Expression of GP73,a resident Golgi membrane protein,in viral and nonviral liver disease.Hepatology,2002,35:1431-1440.
  • 7Kladney RD,Tollefson AE,Wold WS,et al.Upregulation of the Golgi protein GP73 by adenovirus infection requires the E1A CtBP interaction domain.Virology,2002,301:236-246.
  • 8Iftikhar R,Kladney RD,Havlioglu N,et al.Disease-and cellspecific expression of GP73 in human liver disease.Am J Gastroenterol,2004,99:1087-195.
  • 9Block TM,Comunale MA,Lowman M,et al.Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans.Proc Natl Acad Sci U S A,2005,102:779-784.
  • 10Wright LM,Yong S,Picken MM,et al.Decreased Survival and Hepato-Renal Pathology in Mice with C-Terminally Truncated GP73(GOLPH2).Int J Clin Exp Pathol,2009,2:34-47.

共引文献7

同被引文献42

  • 1马琳琳,褚为,张猛,张晓梅.肿瘤标志物联合检测原发性肝癌的研究进展[J].北华大学学报(自然科学版),2012,13(4):441-443. 被引量:2
  • 2杨盛力,潘晓莉.GP73的研究进展[J].肝胆外科杂志,2011,19(1):70-72. 被引量:15
  • 3黄海涛,张筱凤.CA19-9在肝硬化和肝癌中的临床意义[J].临床肝胆病杂志,2006,22(5):379-380. 被引量:19
  • 4Sherman M. Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis. Semin Liver Dis,2010,30( 1 ) :3 - 16.
  • 5Feher J, Lengyel G. Hepatocellular carcinoma : occurrence, risk fac- tors, biomarkers. Orv Hetil,2010,151 (23) :933 - 940.
  • 6Bruix J, Sherman M. Management of hepatocellular carcinoma. Hep- atology ,2005,42 ( 5 ) : 1208 - 1236.
  • 7Wang M, Long RE, Comunale MA, et al. Novel fucosylated biomar- kers for the early detection of hepatocellular carcinoma. Cancer Epi- demiol Biomarkers Prev, 2009, 18 (6) :1914 -1921.
  • 8Mao Y, Yang H, Xu 17, et al. Golgi protein 73 (GOLPH2) is a val- uable serum marker for hepatocellular carcinoma. Gut, 2010, 59 (12) :1687 - 1693.
  • 9Shi Y, Chert J, Li L, A study of diagnostic value of golgi protein GP73 and its genetic assay in primary hepatic carcinoma. Technol Cancer Res Treat, 2011,10 ( 3 ) : 287 - 294.
  • 10Zhou Y, Yin X, Ying J, et al. Golgi protein 73 versus alpha-fetopro- rein as a biomarker for hepatocellular carcinoma: a diagnostic meta-a- nalysis. BMC Cancer, 2012,16 ; 12 : 17.

引证文献2

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部